69 related articles for article (PubMed ID: 26585134)
1. Colocalization of Estrogen Receptors with the Fluorescent Tamoxifen Derivative, FLTX1, Analyzed by Confocal Microscopy.
Morales A; Marín R; Marrero-Alonso J; Boto A; Díaz M
Methods Mol Biol; 2016; 1366():163-173. PubMed ID: 26585134
[TBL] [Abstract][Full Text] [Related]
2. Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.
Marrero-Alonso J; Morales A; García Marrero B; Boto A; Marín R; Cury D; Gómez T; Fernández-Pérez L; Lahoz F; Díaz M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):898-910. PubMed ID: 23727370
[TBL] [Abstract][Full Text] [Related]
3.
Díaz M; Lobo F; Hernández D; Amesty Á; Valdés-Baizabal C; Canerina-Amaro A; Mesa-Herrera F; Soler K; Boto A; Marín R; Estévez-Braun A; Lahoz F
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069498
[TBL] [Abstract][Full Text] [Related]
4. A new selective fluorescent probe based on tamoxifen.
Ho LA; Thomas E; McLaughlin RA; Flematti GR; Fuller RO
Bioorg Med Chem Lett; 2016 Oct; 26(20):4879-4883. PubMed ID: 27662800
[TBL] [Abstract][Full Text] [Related]
5. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
Tyulmenkov VV; Klinge CM
Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
[TBL] [Abstract][Full Text] [Related]
7. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
8. [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen].
Borgna JL; Rochefort H
C R Seances Acad Sci D; 1979 Dec; 289(15):1141-4. PubMed ID: 121266
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
Garcia M; Greene G; Rochefort H; Jensen EV
Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
[TBL] [Abstract][Full Text] [Related]
10. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen aziridines: effective inactivators of the estrogen receptor.
Robertson DW; Wei LL; Hayes JR; Carlson KE; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 1981 Oct; 109(4):1298-300. PubMed ID: 7285873
[TBL] [Abstract][Full Text] [Related]
12. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
[TBL] [Abstract][Full Text] [Related]
14. The steroid binding domain of porcine estrogen receptor.
Koike S; Nii A; Sakai M; Muramatsu M
Biochemistry; 1987 May; 26(9):2563-8. PubMed ID: 3300775
[TBL] [Abstract][Full Text] [Related]
15. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
17. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and estrogen receptor affinity of a 4-hydroxytamoxifen-labeled ligand for diagnostic imaging.
Lashley MR; Niedzinski EJ; Rogers JM; Denison MS; Nantz MH
Bioorg Med Chem; 2002 Dec; 10(12):4075-82. PubMed ID: 12413861
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tamoxifen-specific binding sites and estrogen receptors by estradiol and progesterone in the neonatal uterus of guinea pig.
Gulino A; Pasqualini JR
Endocrinology; 1983 May; 112(5):1871-3. PubMed ID: 6832074
[TBL] [Abstract][Full Text] [Related]
20. Distribution plasticity of the human estrogen receptor alpha in live cells: distinct imaging of consecutively expressed receptors.
Pick H; Jankevics H; Vogel H
J Mol Biol; 2007 Dec; 374(5):1213-23. PubMed ID: 17991486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
